Navigation Links
Bio-Matrix Scientific Group CEO Tells Wall Street Transcript That 'Positive Cash Flow' Is Possible in '09; New Stem Cell Banking Facility Is Growth Vehicle Over the Next Two Years, Says CEO in Exclusive News Interview
Date:3/25/2009

SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- David Koos, Chairman and CEO of San Diego-based Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN), told the editors of The Wall Street Transcript, a New York City financial news weekly, that there is an excellent possibility that the company "would have positive cash flow" in '09 because of new business alliances and contracts "with companies engaged either in cryogenic banking, stem cell research, or cell culturing."

BMSN recently entered into a Human Cell Specimen Cryogenic Storage contract with NeoCells, Inc. and AdultCells, Inc. with a focus on the full spectrum of adult stem cells. BMSN was recently featured as "Stock of The Month" in the KonLin Letter (www.konlin.com), a New York-based investment newsletter, as well as in the WallStreetCorner.com investment newsletter (www.wallstreetcorner.com). The TWST news interview was published in the March 23rd issue.

According to Koos, Bio-Matrix's cGMP compliant 15,000 square foot cryogenic stem cell banking facility is highly secured and technologically advanced and is now gaining the respect of stem cell companies across the nation. "Our business model initially focuses on cord blood and peripheral blood," said Koos. "We have an interest in other stem cells as we roll out our model. Our first step is to develop our revenue stream from cord blood because existing specimens are available. Over the next 18 months, we're looking at enhancing the cord blood specimen and peripheral blood banking strategies."

Koos described Bio-Matrix as a "conservative player in the stem cell industry." The CEO pointed out that the company is developing a unique niche within the stem cell industry as a place for stem cell companies to store blood specimens for research and treatment of diseases. "We are the shipping container, we are the foundation, we're the driveway. We're not rolling the dice on getting FDA approval on some therapy that may take ten years to develop," said Koos in the TWST news interview. "We plan to fill a key niche in the marketplace now."

About Bio-Matrix Scientific Group

Bio-Matrix Scientific Group Inc. (OTCBB: BMSN) is a biotech research and development company that commercializes medical devices and monitoring systems for the growing worldwide stem cell research market. Its new 15,000 square foot facility houses two secure cryogenic stem cell banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing lab, hematology, microbiology and flow cytometry laboratories.

Disclaimer

This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.


'/>"/>
SOURCE Bio-Matrix Scientific Group Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Bio-Matrix Scientific Group Announces New Hires to Management Team
2. Bio-Matrix Scientific Group Featured as Stock Pick in Oakleys Column on WallStreetCorner.com
3. Bio-Matrix Scientific Group, Inc. Highlighted in LifeSciencesWorld.com Special Report; Stem Cell Market Projected to Exceed $8 Billion Worldwide by 2016
4. Bio-Matrix Scientific Group, Inc. Gets Updated Stock Recommendation By KonLin Investment Letter
5. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
6. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
7. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
8. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
9. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Thermo Fisher Scientific to Present at Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016  Blueprint Bio, a company dedicated ... the medical community, has closed its Series A funding ... . "We have received a commitment from ... we need to meet our current goals," stated ... the runway to complete validation on the current projects ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... 2016  Amgen (NASDAQ: AMGN ) today ... life sciences incubator to accelerate the development of ... space at QB3@953 was created to help high-potential life ... many early stage organizations - access to laboratory infrastructure. ... launched two "Amgen Golden Ticket" awards, providing each winner ...
(Date:6/22/2016)... Research and Markets has announced the addition ... their offering. The global ... billion in 2013. The market is expected to grow at a ... 2020, increasing from $50.6 billion in 2015 to $96.6 billion in ... forecast period (2015 to 2020) are discussed. As well, new products ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
Breaking Biology News(10 mins):